Wells Fargo & Company Allakos Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Allakos Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 600 shares of ALLK stock, worth $750. This represents 0.0% of its overall portfolio holdings.

Number of Shares

600

Previous 24,341 97.54%

Holding current value

$750

Previous $30,000 100.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.0 - $1.45 $23,741 - $34,424	-23,741 Reduced 97.54%	600 $0
Q1 2024 May 10, 2024	BUY	$1.02 - $3.23 $3,326 - $10,533	3,261 Added 15.47%	24,341 $30,000
Q4 2023 Feb 09, 2024	BUY	$1.72 - $3.18 $6,955 - $12,859	4,044 Added 23.74%	21,080 $57,000
Q3 2023 Nov 13, 2023	SELL	$2.13 - $5.55 $146,009 - $380,446	-68,549 Reduced 80.09%	17,036 $38,000
Q2 2023 Aug 15, 2023	BUY	$3.6 - $5.25 $77,529 - $113,064	21,536 Added 33.62%	85,585 $373,000
Q1 2023 May 12, 2023	BUY	$4.3 - $8.27 $267,692 - $514,840	62,254 Added 3468.19%	64,049 $285,000
Q4 2022 Feb 13, 2023	SELL	$5.66 - $8.42 $3,877 - $5,767	-685 Reduced 27.62%	1,795 $15,000
Q3 2022 Nov 14, 2022	BUY	$3.02 - $6.12 $2,579 - $5,226	854 Added 52.52%	2,480 $15,000
Q2 2022 Aug 12, 2022	SELL	$2.6 - $6.14 $23,795 - $56,193	-9,152 Reduced 84.91%	1,626 $5,000
Q1 2022 May 16, 2022	SELL	$5.08 - $9.81 $64,043 - $123,674	-12,607 Reduced 53.91%	10,778 $62,000
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $60,439 - $790,950	7,069 Added 43.33%	23,385 $229,000
Q3 2021 Nov 15, 2021	BUY	$76.53 - $110.43 $632,750 - $913,035	8,268 Added 102.73%	16,316 $1.73 Million
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $260,122 - $347,662	3,047 Added 60.93%	8,048 $686,000
Q1 2021 May 13, 2021	SELL	$109.73 - $153.66 $1.52 Million - $2.13 Million	-13,881 Reduced 73.51%	5,001 $574,000
Q4 2020 Feb 09, 2021	BUY	$79.58 - $152.45 $399,412 - $765,146	5,019 Added 36.2%	18,882 $2.64 Million
Q3 2020 Nov 05, 2020	BUY	$66.43 - $90.99 $38,064 - $52,137	573 Added 4.31%	13,863 $1.13 Million
Q2 2020 Aug 13, 2020	BUY	$44.04 - $80.69 $74,956 - $137,334	1,702 Added 14.69%	13,290 $955,000
Q1 2020 May 14, 2020	BUY	$44.49 - $93.39 $515,550 - $1.08 Million	11,588 New	11,588 $515,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

70.7M

Call Options Held

43.8K

Put Options Held

1.4K

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $106M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Allakos Inc. Transaction History